|
| Exchange Disseminated Time 31/01/2017 16:16:10 | Farmax India Ltd has informed BSE that the Board Meeting of the Company will be held on February 13, 2017, to consider and approve the following:
1. Unaudited Q3 results for the quarter ended December 31, 2016.
2. Limited Review report for the quarter ended December 31, 2016.
In this connection, the trading window shall remain closed for all the Directors / Officers / Designated employees / Promoters of the Company from day of February 02, 2017 till day of February 13, 2017 (both days inclusive). |
|
|